The company's asset efficiency, represented by a robust -0.585% return, is a testament to Madrigal Pharmaceuticals, Inc.'s adeptness in optimizing resource deployment. Madrigal Pharmaceuticals, Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -2.199%. Furthermore, the proficiency of Madrigal Pharmaceuticals, Inc. in capital utilization is underscored by a remarkable -0.729% return on capital employed.
Stock Prices
Madrigal Pharmaceuticals, Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $217.82, while its low point bottomed out at $202.2. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Madrigal Pharmaceuticals, Inc.'s stock market.
Liquidity Ratios
Analyzing MDGL liquidity ratios reveals its financial health of the firm.
The current ratio of 537.57% gauges short-term asset coverage for liabilities.
The quick ratio (534.91%) assesses immediate liquidity, while the cash ratio (84.28%) indicates cash reserves.
cards.indicator
cards.value
Current Ratio
537.57%
Quick Ratio
534.91%
Cash Ratio
84.28%
Profitability Ratios
The effective tax rate stands at -1.12%, revealing its tax efficiency.
The net income per EBT, 100.24%, and the EBT per EBIT, 98.20%, provide insights into its earnings hierarchy.
cards.indicator
cards.value
Effective Tax Rate
-1.12%
Net Income per EBT
100.24%
EBT per EBIT
98.20%
Operational Efficiency
Operational metrics shed light on its business agility. With an operating cycle of 5.38, it details the span from stock purchase to revenue.
The 5 days it takes to settle debts showcases its creditor relations.
cards.indicator
cards.value
Days of Sales Outstanding
535
Days of Payables Outstanding
19421
Payables Turnover
0.02
Cash Flow Ratios
Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -16.41, and free cash flow per share, -16.48, depict cash generation on a per-share basis.
The cash per share value, 32.09, showcases liquidity position.
cards.indicator
cards.value
Operating Cash Flow per Share
-16.41
Free Cash Flow per Share
-16.48
Cash per Share
32.09
Free Cash Flow to Operating Cash Flow Ratio
1.00
Cash Flow Coverage Ratio
-2.79
Short Term Coverage Ratio
-615.24
Capital Expenditure Coverage Ratio
-219.22
Dividend Paid and Capex Coverage Ratio
-219.22
Debt and Leverage Ratios
Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 18.11%, highlights its total liabilities relative to assets.
With a debt-equity ratio of 0.29, we discern the balance between debt and equity financing.
The long-term debt to capitalization, 22.17%, and total debt to capitalization, 22.25%, ratios shed light on its capital structure.
An interest coverage of -66.71 indicates its ability to manage interest expenses.
cards.indicator
cards.value
Debt Ratio
18.11%
Debt Equity Ratio
0.29
Long Term Debt to Capitalization
22.17%
Total Debt to Capitalization
22.25%
Interest Coverage
-66.71
Cash Flow to Debt Ratio
-2.79
Company Equity Multiplier
1.58
Per Share Data
Net income per share, -19.99, reflects the portion of profit attributed to each share.
The book value per share, 21.69, represents the net asset value distributed per share, while the tangible book value per share, 21.69, excludes intangible assets.
cards.indicator
cards.value
Net Income Per Share
-19.99
Book Value Per Share
21.69
Tangible Book Value Per Share
21.69
Shareholders Equity Per Share
21.69
Interest Debt Per Share
6.89
Capex Per Share
-0.08
Growth Ratios
EBIT growth, -29.61%, and operating income growth, -29.61%, offer insights into operational profitability progression.
The net income growth, -24.83%, showcases bottom-line expansion, and the EPS growth, -14.42%, measures the growth in earnings per share.
cards.indicator
cards.value
Gross Profit Growth
-12.85%
EBIT Growth
-29.61%
Operating Income Growth
-29.61%
Net Income Growth
-24.83%
EPS Growth
-14.42%
EPS Diluted Growth
-14.42%
Weighted Average Shares Growth
9.05%
Weighted Average Shares Diluted Growth
9.05%
Operating Cash Flow Growth
-44.19%
Free Cash Flow Growth
-44.71%
10-Year Operating CF Growth per Share
54.55%
5-Year Operating CF Growth per Share
-906.47%
3-Year Operating CF Growth per Share
-70.09%
10-Year Net Income Growth per Share
55.05%
5-Year Net Income Growth per Share
-801.63%
3-Year Net Income Growth per Share
-56.41%
10-Year Shareholders Equity Growth per Share
-10.40%
5-Year Shareholders Equity Growth per Share
-32.72%
3-Year Shareholders Equity Growth per Share
39.61%
Asset Growth
76.67%
Book Value per Share Growth
88.31%
Debt Growth
134.90%
R&D Expense Growth
10.75%
SGA Expenses Growth
124.70%
Other Metrics
Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 4,341,255,148.12, captures the company's total value, considering both debt and equity.
Income quality, 0.87, assesses the reliability of reported earnings.
cards.indicator
cards.value
Enterprise Value
4,341,255,148.12
Income Quality
0.87
Capex to Operating Cash Flow
0.46%
Capex to Depreciation
-280.65%
Graham Number
98.78
Return on Tangible Assets
-58.33%
Graham Net Net
21.35
Working Capital
518,733,000
Tangible Asset Value
405,333,000
Net Current Asset Value
402,067,000
Average Payables
25,936,000
Days Payables Outstanding
19421
ROIC
-72.98%
ROE
-0.92%
Valuation Ratios
Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 10.09, and the price to book ratio, 10.09, reflect the market's valuation relative to the company's book value.
Ratios like price to free cash flows, -13.52, and price to operating cash flows, -12.61, gauge market valuation against cash flow metrics.
cards.indicator
cards.value
Price Book Value Ratio
10.09
Price to Book Ratio
10.09
Price Cash Flow Ratio
-12.61
Price Earnings to Growth Ratio
-0.35
Enterprise Value Multiple
-11.76
Price Fair Value
10.09
Price to Operating Cash Flow Ratio
-12.61
Price to Free Cash Flows Ratio
-13.52
Price to Tangible Book Ratio
10.67
Enterprise Value Over EBITDA
-11.43
EV to Operating Cash Flow
-13.39
Earnings Yield
-8.64%
Free Cash Flow Yield
-7.53%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
